| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_648cf972bcbc490fdfd49ce555ea5fcc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9534acd8d2dd9d1f7718c4bebbf26244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1bde28565d28f037e78bf4a67776ee24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b835eb0b878a3c037c1aaaf2edfdfbf1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_612ea203d9889e559c29a8a22bff2592 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-437 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 |
| filingDate |
2008-10-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_df9e8edd995e80bc6f329a7a395bda7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_661c5fa8129a175dbfcd56eb7dc4c7a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59975716107c914c9e4ecc6c778e53c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecb97650db493ba7e430cd92609ad7f6 |
| publicationDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2009056146-A1 |
| titleOfInvention |
Pharmaceutical composition comprising gaboxadol and an inhibitor of patl or oat |
| abstract |
The present invention relates to a pharmaceutical composition comprising gaboxadol or a pharmaceutically acceptable salt thereof and one or more inhibitors of PAT1 and/or one or more inhibitors of OAT. The present invention further relates to a pharmaceutical composition comprising from about 0.5 mg to about 50 mg gaboxadol or a pharmaceutically acceptable salt thereof, wherein the composition provides an in vivo plasma profile comprising a mean Tmax which is longer than about 20 minutes. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11364228-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11597726-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3372229-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3795156-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10765666-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11690829-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11278529-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109715151-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11090293-B2 |
| priorityDate |
2007-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |